Carolyne Zimmermann - Jun 7, 2021 Form 4 Insider Report for 4D Molecular Therapeutics Inc. (FDMT)

Role
Chief Business Officer
Signature
/s/ August J. Moretti, Attorney-in-Fact for Carolyne Zimmermann
Stock symbol
FDMT
Transactions as of
Jun 7, 2021
Transactions value $
$0
Form type
4
Date filed
6/9/2021, 08:28 PM
Next filing
Feb 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Award $0 +60K $0.00 60K Jun 7, 2021 Common Stock 60K $26.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to 25% of the total number of the underlying shares on June 7, 2022, and the remaining shares will vest in equal monthly installments over the following three-year period, such that the stock option will be fully vested on June 7, 2025, subject to the Reporting Person continuing to be a service provider to Issuer through each vesting date.